Search Results

The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.

Antengene Corporation Limited announced that South Korea’s National Health Insurance Service has approved the reimbursement of XPOVIO® for the treatment of adult patients with relapsed or refractory multiple myeloma.

The Foundation for the National Institutes of Health announces that Love Collins, III, has joined as Vice President of Advancement.

Heartbeat Health, the nation’s largest decentralized cardiology provider, and Karoo Health, the only operational provider of cardiac value-based care enablement with published value-based results, announced the formation of a unique value-based enterprise, creating the first national, scalable, end-to-end cardiac value-based care solution for payers, at-risk entities, and provider networks.

The Foundation for the National Institutes of Health announces two additions to the FNIH Board of Directors: James W. Down, former Vice Chairman of Mercer Management Consulting, and Perry Steiner, Chairman and CEO of Xactus.

Kyverna Therapeutics, Inc. announced the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled “Chimeric antigen receptor T cell therapy for autoimmune disease”.

The Foundation for the National Institutes of Health announces the launch of a public-private partnership to build the largest data source for amyotrophic lateral sclerosis and expedite the identification of biomarkers and clinical outcome assessments that would allow earlier diagnosis and accelerated drug development for people living with the disease.

The American Diabetes Association® is pleased to announce this year’s National Scientific and Health Care Achievement Award recipients.